PI-RADS v2.1 paper (for download below)

PI-RADS v2.1

Full PI-RADS v2.1 paper by ACR PI-RADS Steering Committee

Bike our '7-Hills'
to Support our Cancer Research

I fight prostate cancer using MRI, more specifically:

1. Early detection of aggressive prostate cancer with multiparametric-MRI.

2. Introduce PSA-MRI Prostate Cancer screening.

3. Localising 2 mm small nodal metastases with nano- (ferumoxtran-10) MRI.

4. Explore the potential of Artificial Intelligence to detect prostate cancer and nodal metastasis.

https://doi.org/10.1016/j.eururo.2018.11.023

'4M' Study

4M Study: Prospective, multicenter, powered, comparative effectiveness study included 626 biopsy-naïve patients.

RSNA 2018 Hands-on-PI-RADS Course

Download our 

PI-RADS v2.1 Workshop Book

Authors: Jelle Barentsz, Roel Mus, Joyce Bomers, Rianne Engels, Sjoerd Kerkstra, Renske van Delft

Radboudumc, Nijmegen The Netherlands

"In our workshop you will be able to test your skills in detecting “significant” prostate cancer using PI-RADS v2.

Forty-seven cases are presented: 10 for beginners, 10 for intermediate and 27 for advanced participants.

This syllabus presents the clinical data and representative images: T2W, DCE (T1W with Ktrans overlay), ADC and calculated b1400. Based on these you are invited to use your skills and to make your diagnosis."

PI-RADS v2.1

ACR Steering Committee PI-RADS v2.1

PI-RADS v2 Update and Future Directions

PI-RADS Implementation Editorial

PI-RADS v2

Synopsis PI-RADS v2

Combidex-MRI detects small nodal metastases, and improves treatment

This video show the experience of 2 patients with prostate cancer and Combidex MRI

Ferrotran nano-MRI movie

This video shows the working mechanism of Ferrotran for nano-MRI